US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
1. Merck's subsidiary invests in HD, a Southeast Asian healthtech startup. 2. HDmall aims to digitize healthcare and reduce costs for consumers. 3. Startup generated $100 million in annual gross transaction volume last year. 4. Implementation of AI in healthcare enhances customer interactions significantly. 5. HD's B2C2B strategy aims to facilitate enterprise monetization in emerging markets.